PFS survival according to risk groups defined by the model built on baseline TLG and MH
| Risk group and parameter . | N . | PD/relapse . | Median PFS . | 5-year PFS . | 95% CI . |
|---|---|---|---|---|---|
| Low risk | |||||
| Low TLG + Low MH | 45 | 0 | n.r. | 100% | __ |
| Intermediate risk | 49 | 5 | n.r. | 90% | 77-96% |
| Low TLG + High MH | 25 | 1 | n.r. | 96% | 75-99% |
| High TLG + Low MH | 24 | 4 | n.r. | 83% | 61-93% |
| High risk | |||||
| High TLG + High MH | 9 | 8 | 4.3 mo | 11% | 1-39% |
| Risk group and parameter . | N . | PD/relapse . | Median PFS . | 5-year PFS . | 95% CI . |
|---|---|---|---|---|---|
| Low risk | |||||
| Low TLG + Low MH | 45 | 0 | n.r. | 100% | __ |
| Intermediate risk | 49 | 5 | n.r. | 90% | 77-96% |
| Low TLG + High MH | 25 | 1 | n.r. | 96% | 75-99% |
| High TLG + Low MH | 24 | 4 | n.r. | 83% | 61-93% |
| High risk | |||||
| High TLG + High MH | 9 | 8 | 4.3 mo | 11% | 1-39% |
mo, months; n.r., not reached; PD, disease progression.